Skip to main content
SpringerLink
Log in

Entwicklung von retardierend-umhüllten Pellets

  • Chapter
Book cover Arzneiformen-Entwicklung

Part of the book series: Springer-Lehrbuch ((SLB))

  • 216 Accesses

Zusammenfassung

Nach dem Arzneibuch werden Arzneimittel mit veränderter Freisetzung in solche mit verlängerter, verzögerter und pulsierender Freigabe unterteilt. Orale Arzneiformen mit verlängerter Arzneistofffreisetzung und entsprechend erhöhter Dosis bestehen aus Gründen der Freisetzungssicherheit und der raschen Verteilung im Gastrointestinaltrakt bevorzugt aus Pellets, die mit unlöslichen, in gequollenem Zustand jedoch permeablen Hüllen versehen werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Lintz FC (1999) Systematik der Rezepturentwicklung von überzogenen Tabletten und Pellets als Grundlage für ein wissensbasiertes System. Dissertation, Universität Heidelberg

    Google Scholar 

  2. Bauer KH, Lehmann K, Osterwald HP, Rothgang G (1988) Überzogene Arzneiformen 1. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 26

    Google Scholar 

  3. Benedikt G, Steinijans VW, Dietrich R (1988) Galenical development of a new sustainedrelease theophylline pellet formulation for once-daily administration. Drug Res 38(11): 1203–1209

    CAS  Google Scholar 

  4. Bianchini R, Bruni G, Gazzaniga A, Vecchio C (1993) D-indobufen extended-release pellets prepared by coating with aqueous polymer dispersions. Drug Dev Ind Pharm 19: 2021–2041 (1993)

    Article  CAS  Google Scholar 

  5. Chang R-K, Hsiao C (1989) Eudragit RL and RS pseudolatices: properties and performance in pharmaceutical coating as a controlled release membrane for Theophylline Pellets. Drug Dev Ind Pharm 15:187–196

    Article  CAS  Google Scholar 

  6. Chang R-K, Price JC, Hsiao C (1989) Preparation and preliminary evaluation of Eudragit RL and RS pseudolatices for controlled drug release. Drug Dev Ind Pharm 15: 361–372

    Article  CAS  Google Scholar 

  7. Chetty DJ, Dangor CM (1994) The development of an oral controlled release pellets formulation of diethylpropion hydrochloride. Drug Dev Ind Pharm 20: 993–1005

    Article  CAS  Google Scholar 

  8. Dyer AM, Khan KA, Aulton ME (1995) Effect of polymer loading on drug release from film-coated ibuprofen pellets prepared by extrusions-spheronization. Drug Dev Ind Pharm 21:1841–1858

    Article  CAS  Google Scholar 

  9. Podczeck F, Wenzel U ( 1990) „Entwicklung fester peroraler Arzneiformen mit Hilfe multivariater mathematischer Verfahren“. Teil 2: Datenanalyse; Aufdeckung von Zusammenhängen zwischen Einfluss-und Zielgrößen. Pharm Ind 52: 348–351

    CAS  Google Scholar 

  10. Förster H (1981) Entwicklung, Herstellung und Testung peroraler Depotarzneiformen mit konstanter Wirkstoffliberation am Beispiel des Theophyllins. Inauguraldissertation, Universität Düsseldorf

    Google Scholar 

  11. Gilligan CA, Li Wan Po A (1991) Factors affecting drug release from a pellet system coated with an aqueous colloidal dispersion. IntJ Pharm 73: 51–68

    Article  CAS  Google Scholar 

  12. Goohart FW, Harris MR, Murthy KS, Nesbitt RU (1984) An evaluation of aqueous filmforming dispersions for controlled release. Pharm Technol (4): 64–71

    Google Scholar 

  13. Govender T, Dangor CM (1997) Formulation and preparation of controlled-release pellets of salbutamol by the air suspension technique. J Microencapsulation 14: 4455–455

    Google Scholar 

  14. Henning D, Kala H (1986) Einfluss von Weichmachern auf die Permeabilität von Polymethacrylatüberzügen (Eudragit RS). Pharmazie 41: 335–338

    Google Scholar 

  15. Irvin JR, Notari R ( 1991 ) Computer-aided dosage form design. III. Feasability assessment for an oral prolonged-release phenytoin product. Pharm Res 8: 232–237

    Article  PubMed  CAS  Google Scholar 

  16. Junginger HE, Verhoeven J, Danhof M (1989) Oral controlled drug delivery systems based on microporous polymers. Drug Dev Ind Pharm 15:1059–1072

    Article  CAS  Google Scholar 

  17. Laicher A, Lorck CA, Grunenberg PC, Klemm H, Stanislaus F (1993) Aqueous coating of pellets to sustained-release dosage forms in a fluid bed coater. Influence of product temperature and polymer concentration on in vitro release. Pharm Ind 55:1113–1116

    CAS  Google Scholar 

  18. Lee T-Y, Notari R (1987) Computer-aided dosage form design. I. Methods for defining a long-acting first-order delivery system of maximum formulating flexibility. Pharm Res 4:311–316

    Article  PubMed  CAS  Google Scholar 

  19. Lee T-Y, Notari R (1987) Computer-aided dosage form design. II. Methods for defining a zero-order sustained-release delivery system of maximum formulating flexibility. Pharm Res 4: 385–391

    Article  PubMed  CAS  Google Scholar 

  20. Lehmann K (1986) In Wasser dispergierbare, hydrophile Acrylharze mit abgestufter Permeabilität für diffusionsgesteuerte Wirkstoffabgabe aus Arzneiformen. Acta Pharm Technol 32: 146–152

    CAS  Google Scholar 

  21. Lehmann K (1975) Magensaftresistente und retardierende Arzneimittelüberzüge aus wässrigen Acrylharzdispersionen. Acta Pharm Technol 21: 255–260

    CAS  Google Scholar 

  22. Li SP, Feld KM, Kowarski CR (1991) Preparation and evaluation of Eudragit acrylic resins for controlled release of pseudoephedrine hydrochloride. Drug Dev Ind Pharm 17: 1655–1683

    Article  CAS  Google Scholar 

  23. Li SP, Mehta GN, Bueler JD, Grim WM, Harwood RJ (1990) The effect of film-coating additives on the in vitro dissolution release rate of ethyl cellulose-coated theophylline granules. Pharm Technol (3): 20–24

    Google Scholar 

  24. Lippold BC, Förster H ( 1981 ) Diffusion von Theophyllin durch isolierte zuschlaghaltige Ethylcellulose-Membranen. Acta Pharm Technol 27:169–179

    CAS  Google Scholar 

  25. Lippold BC, Lippold BH, Lichey JF (1985) Arzneistofftransport durch lipophile Polymermembranen. 3. Mitt.: Beziehungen zwischen der Diffusionsgeschwindigkeit von Arzneistoffen durch Membranen und deren Eigenschaften. Pharm Ind 47: 1195–1201

    CAS  Google Scholar 

  26. Lippold BC, Lippold BH, Sutter BK, Gunder W (1990) Properties of aqueous, plasticizer-containing Ethyl Cellulose dispersions and prepared films in respect to the production of oral extended release formulations. Drug Dev Ind Pharm 16:1725–1747

    Article  CAS  Google Scholar 

  27. Lippold BH, Sutter BK, Lippold BC (1989) Parameters controlling drug release from pellets coated with aqueous ethyl cellulose dispersion. Int J Pharm 54:15–25

    Article  CAS  Google Scholar 

  28. Lorck CA, Grunenberg PC, Jünger H, Laicher A (1997) Influence of process parameters on sustained-release theophylline pellets coated with aqueous polymer dispersions and organic solvent-based polymer solutions. Drug Dev Ind Pharm 43:149–157

    CAS  Google Scholar 

  29. Lundqvist AEK, Podczeck F, Newton JM (1998) Compaction of, and drug release from, coated drug pellets mixed with other pellets. Eur J Pharm Biopharm 46: 369–379

    Article  PubMed  CAS  Google Scholar 

  30. Marini JO, Mendes RW, Rekhi GS, Jambhekar SS (1991) Some factors affecting the release of drug from membrane coated slow release tablets. Drug Dev Ind Pharm 17: 865–877

    Article  CAS  Google Scholar 

  31. Mathieu C, Huet de Barochez B, Cuiné A (1995) Coating of Pellets: Comparison between Aqueous Dispersion and Alcoholic Solution of Ethylcellulose. Proc 1st World Meeting APGI/APV, Budapest, pp 381–382

    Google Scholar 

  32. Melia CD, Hansraj BR, Khan KA, Wilding IR (1991) A simple and rapid method for the quantification of Eudragit RS 100 and RL100 poly(methacrylates) in sustained-release dosage forms. Pharm Res 8: 899–902

    Article  PubMed  CAS  Google Scholar 

  33. Narisawa S, Nagata M, Ito T, Yoshino H, Hirakawa Y, Noda K (1995) Drug release behaviour in gastrointestinal tract of beagle dogs from multiple unit type rate-controlled or time-controlled release preparations coated with insoluble polymer-based film. J Control Release 33: 253–260

    Article  CAS  Google Scholar 

  34. Nesbitt RU (1994) Effect of formulation components on drug release from multiparticulates. Drug Dev Ind Pharm 20: 3207–3236

    Article  CAS  Google Scholar 

  35. Parikh NH, Porter SC, Rohera BD (1993) Aqueous ethylcellulose dispersion of ethylcellulose. I. Evaluation of coating process variables. Pharm Res 10: 525–534

    Article  PubMed  CAS  Google Scholar 

  36. Porter SC (1989) Controlled-release film coatings based on ethylcellulose. Drug Dev Ind Pharm 15:1495–1521

    Article  CAS  Google Scholar 

  37. Rekhi GS, Porter SC, Jambhekar SS (1995) Factors affecting the release of Propranolol hydrochloride from beads coated with aqueous polymeric dispersions. Drug Dev Ind Pharm 21: 709–729

    Article  CAS  Google Scholar 

  38. Rhodes CT, Porter SC (1998) Coatings for controlled-release drug delivery systems. Drug Dev Ind Pharm 24:1139–1154

    Article  PubMed  CAS  Google Scholar 

  39. Shangraw RF (1988) Design and formulation of sustained release theophylline dosage forms. Drug Dev Ind Pharm 14: 319–335

    Article  CAS  Google Scholar 

  40. Sutter B, Lippold BH, Lippold BC (1988) Polymerfilme als Diffusionsbarrieren für perorale Retardarzneiformen unter besonderer Berücksichtigung wässriger Dispersionen. Acta Pharm Technol 34:179–188

    CAS  Google Scholar 

  41. Thele V ( 1981 ) Untersuchungen zur Permeation ausgewählter Säuren, Basen und Neutralstoffe durch Polyacrylatmembranen. Inauguraldissertation, Ernst-Moritz-Arndt-Universität Greifswald

    Google Scholar 

  42. Thoma K, Knott F (1991) Retardierung schwach basischer Arzneistoffe. Pharm Ind 53: 778–785

    CAS  Google Scholar 

  43. Thoma K, Zimmer T (1989) Retardierung schwach basischer Arzneistoffe. 1. Mitt.: Behebung der Verfügbarkeitsprobleme von Noscapin aus Diffusionspellets. Pharm Ind 51:98–101

    CAS  Google Scholar 

  44. Thoma K, Zimmer T (1989) Retardierung schwach basischer Arzneistoffe. 2. Mitt.: Verbesserung der Verfügbarkeit von Papaverin und Codein aus Diffusionspellets. Pharm Ind 51: 540–543

    CAS  Google Scholar 

  45. Thoma K, Zimmer T (1989) Herstellung und Prüfung von Diffusionspellets mit Kaliumchlorid. Pharm Ind 51: 685–689

    CAS  Google Scholar 

  46. van Bommel EMG, Fokkens JG, Crommelin DJA (1989) Effects of additives on the physico-chemical properties of sprayed ethylcellulose films. Acta Pharm Technol 35: 232–237

    Google Scholar 

  47. Wesdyk R, Joshi YM, De Vincentis J, Newman AW, Jain NB (1993) Factors affecting differences in film thickness of beads coated in fluidized bed units. Int J Pharm 93:101–109

    Article  CAS  Google Scholar 

  48. Wouessidjewe D, Devissaguet JP, Carstensen JT (1991) Effect of multiple film coverage in sustained release pellets. Drug Dev Ind Pharm 17: 7–25

    Article  CAS  Google Scholar 

  49. Zhang G, Schwartz JB, Schnaare RL (1991) Bead coating. I. Change in release kinetics (and mechanism) due to coating levels. Pharm Res 8: 331–335

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmazeutische Technologie und Biopharmazie, Universität Heidelberg, Richard-Lenel-Weg 13a, 69151, Neckargemünd, Deutschland

    Professor Dr. Herbert Sticker

Authors
  1. Professor Dr. Herbert Sticker
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sticker, H. (2003). Entwicklung von retardierend-umhüllten Pellets. In: Arzneiformen-Entwicklung. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18982-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18982-1_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62393-6

  • Online ISBN: 978-3-642-18982-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation